BackConduit Pharmaceuticals Overview

Conduit Pharmaceuticals Total Revenue

Revenue analysis for CDT.

Quarterly Revenue

$696.38M
11.44% YoY

As of Mar 2026

Annual Revenue (TTM)

$2.79B
9.5% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading